Turnover Talk: Allied Health Clinical Procedures
Discussion of considerations, technique and common office procedures in gynecologic oncology.
Category
  • Allied Health Professionals
  • Turnover Talks
  • Cervix
  • Endometrium
  • Clinical Practice
Format
  • On-Demand
Credits
Turnover Talk: Allied Health Lynch Syndrome
Discussion regarding diagnosis and management of LYNCH syndrome.
Category
  • Allied Health Professionals
  • Turnover Talks
  • Genetics
Format
  • On-Demand
Credits
Turnover Talk: Allied Health PARPs
Discussion of current trials and indications for PARPs in Ovarian cancer.
Category
  • Allied Health Professionals
  • Turnover Talks
  • PARPi
  • Immunotherapy
Format
  • On-Demand
Credits
Turnover Talk: Allied Health Sexual Health
Discussion of sexual health issues among gynecologic oncology patients.
Category
  • Allied Health Professionals
  • Turnover Talks
Format
  • On-Demand
Credits
Turnover Talk: Allied Health Wound Care
Discussion of issues related to delayed wound healing, wound care techniques, and the role of wound care specialists.
Category
  • Allied Health Professionals
  • Turnover Talks
Format
  • On-Demand
Credits
Turnover Talk: Current Treatment Decisions for Front Line Ovarian Cancer
Discussion of maintenance therapy with PARPi, or bevacizumab, and improvement in progression free survival after front line treatment for advanced high grade epithelial ovarian cancer
Category
  • Turnover Talks
  • Ovary
  • PARPi
Format
Credits
Turnover Talk: Evaluation and Management Coding for 2021
Discussion of 2021 changes to E&M coding for outpatient visits for billing by time and medical complexity.
Category
  • Turnover Talks
  • Coding
Format
  • On-Demand
Credits
Turnover Talk: Immunotherapy Toxicity
Review of immunotherapy toxicity including timeline and symptoms of endocrinopathies, nephritis, hepatitis, colitis, pneumonitis; treatment for IRAEs; rechallenging patients after resolution of IRAEs.
Category
  • Turnover Talks
  • Immunotherapy
Format
  • On-Demand
Credits
Turnover Talk: Molecular Testing and Patient Selection in Ovarian Cancer
A brief discussion of homologous recombination deficiency, loss of heterozygosity, and molecular markers in ovarian cancer, and how this can guide therapy.
Category
  • Turnover Talks
  • Ovary
  • Genetics
  • Targeted Therapy
Format
  • On-Demand
Credits
Turnover Talk: Novel Discoveries in Endometrial Cancer: Are we finally making progress?
Novel treatments in advanced or recurrent endometrial cancer including targeted therapies and immunotherapies.
Category
  • Turnover Talks
  • Endometrium
  • Pharmacology
  • Targeted Therapy
  • Immunotherapy
  • Chemotherapy
Format
  • On-Demand
Credits

Pages